China
China’s Lyfe Capital raises $420m for second healthcare fund
China-based healthcare specialist Lyfe Capital has raised more than $420 million for its second fund, which comprises parallel US dollar and renminbi-denominated tranches.
Partners Group confirms China restaurant chain investment
Partners Group has confirmed its investment in Green Tea Restaurant, having acquired a substantial minority stake in the leading Chinese casual dining chain for an undisclosed sum.
Warburg Pincus leads $120m round for China’s Yuanfudao
Warburg Pincus has led a $120 million round of funding for China’s Yuanfudao in what is said to be the largest-ever PE investment in the country's online tutoring industry.
Sequoia, Perfect World back China online bookstore business
Sequoia Capital China has co-led a funding round for online reading business Zongheng Literature, working in tandem with Perfect World, the Chinese movies-to-gaming company that controls Zongheng.
Tech investors leverage changing Chinese consumption patterns
The disruption caused by technology in China's consumer and business services sectors - and the change this brings to traditional business models - is generating increased deal flow for private equity and venture capital investors.
Bain to buy $200m Chinese NPL portfolio
Bain Capital Credit (BCC) has agreed to buy a portfolio of Chinese non-performing loans (NPLs) worth approximately $200 million, reflecting the growing interest from foreign investors in the country’s distressed debt space.
China's Bona Film forms $150m fund with US-based CAA
Chinese film distributor Bona Film Group, which is backed by a handful of PE and strategic investors, has teamed up with Hollywood talent agency Creative Artists Agency (CAA) to launch a $150 million film fund.
China automobile services platform Lechebang gets $44m
Lechebang, a Chinese online automobile services platform focused on after-sale services, has completed a RMB300 million ($44 million) Series B round led by Grand Flight Investment.
China genomics: Coded messages
Investors are looking to tap the massive potential of China’s genomic industry, with a particular focus on companies that leverage large amounts of patient data to support drug development and testing services
CITIC Capital in $600m Australian health acquisition
CITIC Capital China has joined a consortium including China’s Humanwell Healthcare to acquire the sexual health division of Australia-listed medical products supplier Ansell for $600 million.
PE-backed UrWork, 5Lmeet get $116m from Beijing Xingpai
Chinese PE-backed co-working space operators UrWork and 5Lmeet – both of which were founded by Daqing Mao, formerly a real estate executive at China Vanke – have raised a total of RMB800 million ($116 million) from conglomerate Beijing Xingpai Group.
China biopharma player gets $25m Series B
CANbridge Life Science, a Beijing-based clinical-stage biopharmaceutical company focused on developing Western drug candidates in China and North Asia, has raised a Series B round worth $25 million.
China mobile communication app Chubao raises $100m
Shanghai-based mobile communication app developer Chubao Technology has completed a $100 million Series D round co-led by CCB International, an investment unit of China Construction Bank, and China PE firm HG Capital.
Deal focus: Wish scales up cross-border e-commerce
Wish secures an extended Series F round to build out its platform that enables Chinese suppliers to sell cut-price goods to US and European consumers
Co-working spaces in Asia: Spaced out
Co-working spaces are proliferating in Asia as companies – from multinationals to start-ups – opt for more flexible real estate arrangements. The transition is real, but are the valuations justified?
Sino-Australian consortium to buy Icon Group from Quadrant
QIC, Goldman Sachs and Pagoda Investment – a China-focused private equity firm set up by a former QIC executive – have agreed to buy Icon Group, an Australian oncology services provider, from Quadrant Private Equity.
Frontline BioVentures merges with WuXi Ventures
Chinese healthcare specialists Frontline BioVentures and WuXi Healthcare Ventures have merged, forming a new investment firm called 6 Dimensions Capital.
China’s Cloudwise raises $26m from VCs
CBC Capital has led a $26 million Series C round for Cloudwise, a Beijing-based application performance management (APM) solutions provider, with participation from SIG Asia and Sequoia Capital China.
CDH makes another partial exit from WH Group
CDH Investments has completed its third partial exit from WH Group in nine months, generating proceeds of HK$5.78 billion ($743 million) and reducing its holding in the Chinese pork producer to 3.24%.
Lightspeed China closes debut renminbi fund at $87m
Lightspeed China Partners has closed its first renminbi-denominated venture fund at RMB600 million ($87 million).
China aerospace player launches $22b tech fund
China Aerospace Science & Technology Corporation (CASC) has launched a RMB150 billion ($22 billion) fund with a group of state-owned enterprises (SOEs) to invest in new technologies.
CDH-backed Zhenghai Bio-tech jumps on Shenzhen debut
Yantai Zhenghai Bio-tech, a Chinese biotechnology company backed by CDH Investments, saw its stock gain 44.03% on its first day of trading following a RMB234 million ($34 million) IPO in Shenzhen.
Ping An leads $75m round for YY's gaming subsidiary Huya
China Ping An Insurance has led a $75 million Series A round for Huya, the live game broadcasting subsidiary of Chinese social networking platform YY.
Cross-border e-commerce site Wish raises new round
Wish, a San Francisco-based cross-border e-commerce app backed by several Asian investors, has completed a Series F round led by Everbright-IDG Industrial Fund.